Showing 5771-5780 of 20432 results for "".
- Durvalumab Revolutionizes Perioperative Bladder Cancer Treatmenthttps://reachmd.com/news/durvalumab-revolutionizes-perioperative-bladder-cancer-treatment/2475418/The recent Durvalumab approved for perioperative bladder cancer use represents a significant advance in muscle-invasive bladder cancer management, providing a neoadjuvant strategy that
- Monoclonal Antibodies: Transforming RSV Prevention in Pediatricshttps://reachmd.com/news/monoclonal-antibodies-transforming-rsv-prevention-in-pediatrics/2475421/RSV continues to drive substantial infant hospitalizations each winter, with about 58,000 to 80,000 children under five years hospitalized annually in the U.S. RSV proph
- The Role of FOXA1 Mutations in Prostate Cancer Resistancehttps://reachmd.com/news/the-role-of-foxa1-mutations-in-prostate-cancer-resistance/2475435/Recent studies have demonstrated that FOXA1 mutations contribute to prostate tumor growth and therapeutic resistance, suggesting a potential shift toward precision-targeted interventions. However, further research is needed to fully establish
- Evolving Prostate Cancer Therapies: Reducing Toxicity in Treatment Regimenshttps://reachmd.com/news/evolving-prostate-cancer-therapies-reducing-toxicity-in-treatment-regimens/2475427/Oncologists confronting metastatic castration-sensitive prostate cancer are increasingly favoring therapies that spare patients the toxicity of traditional cytotoxic regimens, reshaping treatment algorithms and quality of life expectations.</
- Managing Postoperative Delirium in Hypertensive Geriatric Patientshttps://reachmd.com/news/managing-postoperative-delirium-in-hypertensive-geriatric-patients/2475401/A 78-year-old man with long-standing hypertension undergoes hip replacement and, despite stable intraoperative hemodynamics, awakens confused and agitated—a common presentation of postoperative delirium in geriatric patients. Managing
- Rethinking Fibrosis Management in Crohn's Disease: From Genetics to Targeted Therapyhttps://reachmd.com/news/rethinking-fibrosis-management-in-crohns-disease-from-genetics-to-targeted-therapy/2475407/Fibrosis in Crohn’s disease results from excessive collagen deposition by fibroblasts, leading to gut strictures and obstructions that often necessitate surgical interventions.
- Psychomotor and Visual-Spatial Training in Ultrasound Educationhttps://reachmd.com/news/psychomotor-and-visual-spatial-training-in-ultrasound-education/2475408/Rapid, bedside ultrasound has become indispensable in emergency care, yet traditional curricula often overlook psychomotor and visual-spatial abilities that research indicates are crucia
- Lebrikizumab: Bridging the Skin-Mind Gap in Atopic Dermatitishttps://reachmd.com/news/lebrikizumab-bridging-the-skin-mind-gap-in-atopic-dermatitis/2475395/Patients with moderate-to-severe atopic dermatitis contend with relentless skin inflammation and a parallel psychological burden—yet treatment often targets one domain at the expense of the other. At the XIV International Congress of D
- Emerging Frontiers in COVID-19 Vaccination and Gut Microbiota Biotherapeuticshttps://reachmd.com/news/emerging-frontiers-in-covid-19-vaccination-and-gut-microbiota-biotherapeutics/2475400/Emerging Frontiers in COVID-19 Vaccination and Gut Microbiota Biotherapeutics As Omicron subvariants challenge our defenses, updated vaccine formulations offer renewed protection against severe illness, while early-sta
- Exploring the Gut-Lung Axis: New Frontiers in COVID-19 Therapeuticshttps://reachmd.com/news/exploring-the-gut-lung-axis-new-frontiers-in-covid-19-therapeutics/2475394/While current research on the gut-lung axis underscores its potential to influence COVID-19 therapeutics by showing that gut microbes can modulate respiratory immunity, most evidence is derived from preclinical studies, highl